OrganiGram Historical Cash Flow
| OGI Stock | USD 1.51 0.01 0.67% |
Analysis of OrganiGram Holdings cash flow over time is an excellent tool to project OrganiGram Holdings future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 34.8 M or End Period Cash Flow of 27.4 M as it is a great indicator of OrganiGram Holdings ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining OrganiGram Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether OrganiGram Holdings is a good buy for the upcoming year.
OrganiGram |
About OrganiGram Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in OrganiGram balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which OrganiGram's non-liquid assets can be easily converted into cash.
OrganiGram Holdings Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by OrganiGram Holdings to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of OrganiGram Holdings operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in OrganiGram Holdings financial statement analysis. It represents the amount of money remaining after all of OrganiGram Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from OrganiGram Holdings' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into OrganiGram Holdings current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.As of now, OrganiGram Holdings' Depreciation is increasing as compared to previous years. The OrganiGram Holdings' current Other Non Cash Items is estimated to increase to about 183.3 M, while Sale Purchase Of Stock is projected to decrease to under 33.7 M.
OrganiGram Holdings cash flow statement Correlations
Click cells to compare fundamentals
OrganiGram Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OrganiGram Holdings cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (23.0M) | 30.8M | 13.2M | (68.5M) | (61.7M) | (58.6M) | |
| Free Cash Flow | (123.8M) | (40.9M) | (85.0M) | (62.7M) | (56.4M) | (59.2M) | |
| Change In Working Capital | 29.0M | 24.2M | (22.9M) | 12.5M | 14.4M | 15.1M | |
| Begin Period Cash Flow | 47.6M | 24.6M | 55.4M | 68.5M | 78.8M | 82.7M | |
| Other Cashflows From Financing Activities | (3.0M) | 6.0M | 6.3M | (754.2K) | (867.3K) | (823.9K) | |
| Capital Expenditures | 78.7M | 12.3M | 48.8M | 26.9M | 30.9M | 34.8M | |
| Total Cash From Operating Activities | (45.1M) | (28.6M) | (36.2M) | (35.8M) | (32.2M) | (30.6M) | |
| Net Income | (136.2M) | (130.7M) | (14.3M) | (229.5M) | (206.5M) | (196.2M) | |
| Total Cash From Financing Activities | 160.4M | 174.5M | 5.3M | (754.2K) | (867.3K) | (823.9K) | |
| End Period Cash Flow | 24.6M | 55.4M | 68.5M | 33.9M | 38.9M | 27.4M | |
| Stock Based Compensation | 7.8M | 3.9M | 5.1M | 5.3M | 6.1M | 4.6M | |
| Change To Inventory | (40.9M) | 45.6M | 28.7M | (12.2M) | (14.1M) | (13.3M) | |
| Depreciation | 18.0M | 31.0M | 24.9M | 24.1M | 27.7M | 29.1M | |
| Other Non Cash Items | 46.7M | 776K | (29.0M) | 151.8M | 174.6M | 183.3M | |
| Change To Account Receivables | 1.8M | (6.0M) | (24.0M) | 12.5M | 11.3M | 11.8M | |
| Investments | (138.2M) | (72.5M) | 95.5M | 20.1M | 23.2M | 24.3M | |
| Net Borrowings | 64.0M | (116.4M) | (1.0M) | (772.6K) | (695.4K) | (660.6K) | |
| Total Cashflows From Investing Activities | (138.2M) | (115.1M) | 44.0M | 4.6M | 5.2M | 5.5M | |
| Change To Operating Activities | (13.5M) | 9.6M | (542K) | 1.2M | 1.4M | 1.5M | |
| Other Cashflows From Investing Activities | (7.6M) | (30.3M) | 5.8M | 11.6M | 10.4M | 10.9M | |
| Change To Netincome | 44.0M | 46.1M | (24.0M) | 174.6M | 200.8M | 210.8M | |
| Change To Liabilities | (28.0M) | 2.1M | 12.1M | (17.6M) | (15.8M) | (15.0M) |
Currently Active Assets on Macroaxis
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.79) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.